🇺🇸 FDA
Company

PROVECTUS

PROVECTUS BIOPHARMACEUTICALS, INC.

PVCT biotech USA

Quick answer

PROVECTUS is a biotech company (PVCT) headquartered in KNOXVILLE, TN, USA with 12 tracked pipeline programs.

Pipeline (12)

project

PV-10 (10% rose bengal disodium)

Cutaneous Melanoma

Phase 3 · small_molecule · terminated

1 trials project

PH-10

Atopic Dermatitis

Phase 2 · small_molecule · completed

1 trials project

PH-10 (0.001% Rose Bengal)

Psoriasis

Phase 2 · small_molecule · completed

1 trials project

PH-10 (0.002% Rose Bengal)

Psoriasis

Phase 2 · small_molecule · completed

1 trials project

PH-10 (rose bengal disodium 0.001%)

Plaque Psoriasis

Phase 2 · small_molecule · terminated

1 trials project

PV-10

Melanoma

Phase 2 · small_molecule · active

2 trials project

PV-10 (10% rose bengal disodium)

Melanoma

Phase 2 · small_molecule · completed

1 trials project

Topical Rose Bengal, 0.005%

Psoriasis

Phase 2 · small_molecule · completed

1 trials project

PV-10 (10% rose bengal disodium)

Cancer Metastatic to the Liver

Phase 1 · small_molecule · active

1 trials project

PV-10 (rose bengal disodium 10%)

Breast Cancer

Phase 1 · small_molecule · completed

1 trials project

PV-10 (rose bengal disodium, 10%)

Melanoma

Phase 1 · small_molecule · completed

1 trials project

Rose bengal disodium

Neuroendocrine Tumors Metastatic to the Liver

Phase 1 · small_molecule · active

1 trials

Patents (8)

patent

US 12377068

In vitro and xenograft anti-tumor activity of a halogenated-xanthene against ref

Expires Mon Jul 31 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12133840

Halogenated xanthene composition and method for treating hematologic cancers

Expires Mon Oct 31 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12064507

Composition and method for oral treatment of leukemia

Expires Mon Aug 15 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11975106

Uses of halogenated xanthenes in oncology and virology

Expires Mon May 02 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11974980

In vitro and xenograft anti-tumor activity of a halogenated-xanthene against ref

Expires Mon May 02 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11938182

Halogenated xanthenes as vaccine adjuvants

Expires Mon Mar 21 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11426379

Combination of local and systemic therapies for enhanced treatment of dermatolog

Expires Mon Aug 25 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11419844

Halogenated xanthene composition and method for treating hematologic cancers

Expires Mon Aug 18 2042 00:00:00 GMT+0000 (Coordinated Universal Time)